Showing results (1191-1200 of 1,717) with videos related to

Sort By:
Pageof 172
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia]Q S Hao, Z Wang, Q Y Fang, et al.
Psychological Medicine|August 29, 2015
Altered corticostriatal functional connectivity in individuals with high social anhedoniaY Wang, W-H Liu, Z Li, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 23, 2022
[Functional outcomes of 100 patients with adenocarcinoma of the esophagogastric junction undergoing Cheng's GIRAFFE(®) reconstruction after proximal gastrectomy]Y Q Zhang, Z Y Xu, Y A Du, et al.
Blood Advances|January 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)Chong Chyn Chua, Sun Loo, Chun Yew Fong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.
Blood|July 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AMLRithin Nedumannil, Michael Ashby, James P Rowland, et al.
Nature Chemical Biology|July 11, 2006
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivoM Germana Sanna, Sheng-Kai Wang, Pedro J Gonzalez-Cabrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid LeukemiaMarina Konopleva, Michael J Thirman, Keith W Pratz, et al.
Pageof 172